[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
The authors presents the state of knowledge on the prevalence and proposed mechanisms leading to weight gain during treatment with atypical antipsychotics. A short review on the therapeutic approaches is also supplied.
Klinika Zaburzeń Afektywnych, Psychotycznych i Psychiatrii Młodziezowej, Katedry Psychiatrii, Uniwersytetu Medycznego w Lodzi.
Adrian
A
Kostulski
Anna
A
Wyszogrodzka-Kucharska
Jolanta
J
Rabe-Jabłońska
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001835:Body Weight / Q000187:drug effects*; D003024:Clozapine / Q000009:adverse effects; D003987:Dibenzothiazepines / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D020738:Leptin / Q000378:metabolism; D010879:Piperazines / Q000009:adverse effects; D011618:Psychotic Disorders / Q000188:drug therapy; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000009:adverse effects; D013844:Thiazoles / Q000009:adverse effects; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D020738:Leptin; D010879:Piperazines; D013844:Thiazoles; D000069348:Quetiapine Fumarate; C092292:ziprasidone; D003024:Clozapine; D018967:Risperidone